Yosuke Kitagawa

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Bipedicled Laterally Based Pericranial Flap for Anterior Skull Base Reconstruction.

Bipedicled Laterally Based Pericranial Flap for Anterior Skull Base Reconstruction.

Journal: The Journal of craniofacial surgery

Published: July 07, 2026

Systemic immune-inflammation and response indices is associated with early but not long-term survival after primary stereotactic radiosurgery for brain metastases.

Systemic immune-inflammation and response indices is associated with early but not long-term survival after primary stereotactic radiosurgery for brain metastases.

Journal: British journal of neurosurgery

Published: June 10, 2026

Imaging diagnosis of adult-type diffuse gliomas in the era of WHO CNS5 and cIMPACT-NOW updates 8-11: a narrative review.

Imaging diagnosis of adult-type diffuse gliomas in the era of WHO CNS5 and cIMPACT-NOW updates 8-11: a narrative review.

Journal: Japanese journal of radiology

Published: May 02, 2026

Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.

Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.

Journal: International journal of molecular sciences

Published: March 20, 2026

Conventional MRI/CT for differentiation of IDH-mutant adult-type diffuse gliomas: revisited with a new imaging feature "scFLAIR-D".

Conventional MRI/CT for differentiation of IDH-mutant adult-type diffuse gliomas: revisited with a new imaging feature "scFLAIR-D".

Journal: Japanese journal of radiology

Published: November 16, 2025

Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cells.

Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cells.

Journal: Neuro-oncology advances

Published: October 19, 2025

Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases.

Systemic immune-inflammation index as a prognostic biomarker to predict overall survival after primary stereotactic radiosurgery for brain metastases.

Journal: Journal of neuro-oncology

Published: August 04, 2025

Histologically indolent but widely disseminated diffuse midline glioma H3K27-altered revealed by autopsy.

Histologically indolent but widely disseminated diffuse midline glioma H3K27-altered revealed by autopsy.

Journal: Brain tumor pathology

Published: July 21, 2025

Late-onset intracranial adenocarcinoma arising from a germ cell tumor 25 years after initial diagnosis.

Late-onset intracranial adenocarcinoma arising from a germ cell tumor 25 years after initial diagnosis.

Journal: Brain tumor pathology

Published: June 03, 2025

Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy.

Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy.

Journal: Cells

Published: June 01, 2025

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Journal: Science (New York, N.Y.)

Published: July 11, 2024

CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition.

CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 20, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026